北京天元（杭州）律师事务所 关于思创医惠科技股份有限公司 2025 年第六次临时股东会的法律意见 京天股字（2025）第 730 号 致：思创医惠科技股份有限公司 思创医惠科技股份有限公司（以下简称"公司"）2025 年第六次临时股东会（以 下简称"本次股东会"）采取现场表决与网络投票相结合的方式，现场会议于 2025 年 12 月 3 日（星期三）下午 14:30 在公司会议室（浙江省杭州市滨江区月明路 567 号"医惠中心"23 楼会议室）召开。北京天元（杭州）律师事务所（以下简称"本 所"）接受公司聘任，指派本所律师参加本次股东会现场会议，并根据《中华人民 共和国公司法》、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市 公司股东会规则》（以下简称"《股东会规则》"）以及《思创医惠科技股份有限 公司章程》（以下简称"《公司章程》"）等有关规定，就本次股东会的召集、召开 程序、出席现场会议人员的资格、召集人资格、会议表决程序及表决结果等事项出 具本法律意见。 为出具本法律意见，本所律师审查了《思创医惠科技股份有限公司第六届董 事会第十三次会议决议公告》、《思创医惠科技股份有限公司关于召开 202 ...

证券代码：300078 证券简称：思创医惠 公告编号：2025-116 思创医惠科技股份有限公司 2025 年第六次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会未出现否决议案的情形。 6、会议主持人：公司董事长魏乃绪先生 2、本次股东会未涉及变更以往股东会已通过的决议。 一、会议召开情况 1、现场会议召开时间：2025 年 12 月 3 日（星期三）14:30 2、网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 12 月 3 日 9:15-9:25，9:30-11:30，13:00-15:00； 通过深圳证券交易所互联网投票系统投票的具体时间为：2025 年 12 月 3 日 9:15 至 15:00 期间的任意时间。 3、现场会议召开地点：浙江省杭州市滨江区月明路 567 号"医惠中心"23 楼会议室 4、会议召开方式：本次股东会采取现场投票表决和网络投票表决相结合的 方式 5、会议召集人：公司董事会 7、会议召开的合法、合规性：本次股东会的召集、召开及表决程序符合《中 华人 ...

证券代码：300078 证券简称：思创医惠 公告编号：2025-117 思创医惠科技股份有限公司 第六届董事会第十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二、董事会会议审议情况 一、董事会会议召开情况 思创医惠科技股份有限公司（以下简称"公司"）第六届董事会第十四次会 议于 2025 年 12 月 3 日在浙江省杭州市滨江区月明路 567 号"医惠中心"23 楼 会议室以现场表决和通讯表决相结合的方式召开。会议通知于 2025 年 11 月 28 日通过电子邮件、电话方式送达各位董事。本次会议应出席董事 8 人，实际出席 董事 8 人。因公司董事许益冉先生已向董事会辞去董事长职务，经董事会过半数 的董事共同推举，本次会议由董事魏乃绪先生召集并主持，公司高级管理人员列 席了会议。本次会议的召集、召开和表决程序符合《中华人民共和国公司法》（以 下简称"《公司法》"）等法律法规和《公司章程》的规定。 （3）将第六届董事会薪酬与考核委员会委员叶肖剑先生调整为何毅琦先生。 1、审议通过了《关于选举第六届董事会董事长、代表公司执行公司事务的 董事 ...

Core Insights - The DRG/DIP concept sector experienced a decline of 0.89%, ranking among the top losers in the market [1] - Notable stocks within the sector included Langchao Software, Jiayuan Technology, and Digital Certification, which saw significant declines, while Shichuang Medical, Taiji Co., and Saili Medical were among the few that increased in value [1] Market Performance - The top-performing concept sectors included Smart Speakers (+3.71%), AI Phones (+3.39%), and Zinc Metals (+2.86%), while the DRG/DIP sector was among the laggards with a decline of 0.89% [2] - The DRG/DIP sector faced a net outflow of 311 million yuan, with 17 stocks experiencing net outflows, and 9 stocks seeing outflows exceeding 10 million yuan [2] Key Stocks and Fund Flow - Langchao Software led the outflow with a net withdrawal of 148 million yuan, followed by Rongke Technology and Shichuang Medical with outflows of 53.22 million yuan and 32.94 million yuan, respectively [2][3] - Conversely, Taiji Co., Weining Health, and Guoxin Health were the top gainers in terms of net inflow, attracting 41.91 million yuan, 16.34 million yuan, and 7.48 million yuan, respectively [2] Detailed Stock Movements - Langchao Software saw a decline of 6.01% with a turnover rate of 22.29% and a net outflow of 147.51 million yuan [2][3] - Other notable declines included Rongke Technology (-2.50%), Shichuang Medical (+4.18%), and Donghua Software (-0.20%) [2][3] - Taiji Co. and Weining Health showed positive movements with increases of 1.60% and 1.28%, respectively, while Guoxin Health remained stable with a slight decrease of 0.20% [2][3]

思创医惠所属申万行业为：计算机-IT服务Ⅱ-IT服务Ⅲ。所属概念板块包括：DRG概念、家庭医生概 念、多胎概念、新零售、小盘等。 截至9月30日，思创医惠股东户数5.84万，较上期减少11.34%；人均流通股19077股，较上期增加 12.79%。2025年1月-9月，思创医惠实现营业收入6.04亿元，同比增长6.95%；归母净利润-476.22万元， 同比增长98.32%。 分红方面，思创医惠A股上市后累计派现5.32亿元。近三年，累计派现0.00元。 责任编辑：小浪快报 12月1日，思创医惠（维权）盘中下跌2.20%，截至10:18，报4.45元/股，成交2.08亿元，换手率4.13%， 总市值49.75亿元。 资金流向方面，主力资金净流出3019.09万元，特大单买入113.67万元，占比0.55%，卖出1131.77万元， 占比5.45%；大单买入2875.68万元，占比13.85%，卖出4876.67万元，占比23.49%。 思创医惠今年以来股价涨46.38%，近5个交易日跌8.81%，近20日涨23.96%，近60日涨23.27%。 今年以来思创医惠已经5次登上龙虎榜，最近一次登上龙虎榜为11月1 ...

Core Viewpoint - The stock price of Sichuang Medical has increased significantly this year, with a notable rise in recent trading days, indicating strong market interest and potential growth in the healthcare technology sector [2]. Group 1: Stock Performance - Sichuang Medical's stock price has risen by 54.61% year-to-date, with a 4.21% increase in the last five trading days, a 32.02% increase over the last 20 days, and a 27.37% increase over the last 60 days [2]. - The company has appeared on the stock market's "Dragon and Tiger List" five times this year, with the most recent appearance on November 19 [2]. Group 2: Company Overview - Sichuang Medical, established on November 21, 2003, and listed on April 30, 2010, is based in Hangzhou, Zhejiang Province, and focuses on smart hospital solutions, disease research management, and AI services in healthcare [2]. - The company's revenue composition includes 53.84% from real estate sales, 39.28% from business intelligence, and 6.87% from smart healthcare [2]. - Sichuang Medical is classified under the computer-IT services industry and is associated with various concepts such as DRG, family doctor, and new retail [2]. Group 3: Financial Performance - For the period from January to September 2025, Sichuang Medical reported a revenue of 604 million yuan, reflecting a year-on-year growth of 6.95%, while the net profit attributable to shareholders was -4.76 million yuan, showing a significant year-on-year improvement of 98.32% [2]. - As of September 30, the number of shareholders was 58,400, a decrease of 11.34% from the previous period, while the average circulating shares per person increased by 12.79% to 19,077 shares [2]. Group 4: Dividend Information - Since its A-share listing, Sichuang Medical has distributed a total of 532 million yuan in dividends, with no dividends paid in the last three years [3].

Core Viewpoint - The company, Sichuang Medical (300078), focuses on commercial intelligence business, providing IoT solutions for various industries, emphasizing digital retail and supply chain management [1] Group 1: Business Overview - The main business of the company is commercial intelligence, based on the development and production of EAS and RFID technologies [1] - The company aims to change lives through the concept of "Internet of Things" and offers integrated hardware and software services [1] Group 2: Industry Applications - The company provides deep applications of IoT solutions in sectors such as unmanned retail, smart loss prevention, clothing supply chain, and smart cities [1] - The solutions are designed to facilitate digital retail and comprehensive supply chain management [1] Group 3: Future Plans - The company is considering a name change, which will be evaluated based on strategic development plans, business layout, and regulatory requirements [1] - Any necessary disclosures regarding the name change will be made in accordance with legal regulations [1]

Core Viewpoint - The company has transitioned its main business focus from smart medical services to commercial intelligence, specifically in the field of chip technology and IoT solutions [1] Group 1: Business Transition - The company has officially divested its smart medical business and is now concentrating on commercial intelligence [1] - The new business model is based on EAS and RFID development, providing IoT solutions for various industries such as unmanned retail, smart loss prevention, clothing supply chain, and smart cities [1] Group 2: Future Plans - The company is considering a name change to better reflect its current business focus, but this will depend on strategic development plans, business layout, and regulatory requirements [1] - Any future disclosures regarding the name change will be made in compliance with legal and regulatory obligations [1]

Core Viewpoint - The AI medical sector experienced a significant increase of 3.48% on November 24, with leading stock performance from Sichuang Medical [1] Group 1: Market Performance - On November 24, the Shanghai Composite Index closed at 3836.77, up 0.05%, while the Shenzhen Component Index closed at 12585.08, up 0.37% [1] - The top-performing stocks in the AI medical sector included Sichuang Medical, which rose by 8.20% to a closing price of 4.88, and Chengdu Xian Dao, which increased by 6.61% to 22.90 [1] Group 2: Trading Volume and Capital Flow - The AI medical sector saw a net inflow of 136 million yuan from institutional investors, while retail investors contributed a net inflow of approximately 99.92 million yuan [1] - The trading volume for Sichuang Medical reached 2.345 million shares, with a transaction value of 1.11 billion yuan [1] Group 3: Individual Stock Capital Flow - Notable net inflows from institutional investors included 67.19 million yuan for Weining Health, 38.08 million yuan for Rundar Medical, and 33.69 million yuan for Jiuyuan Yinhai [2] - Conversely, retail investors showed net outflows in several stocks, including 47.88 million yuan for Weining Health and 55.12 million yuan for Jiuyuan Yinhai [2]

Core Viewpoint - The internet healthcare sector experienced a rise of 1.26% on November 24, with Focus Technology leading the gains, while the overall market indices showed modest increases [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3836.77, up 0.05%, and the Shenzhen Component Index closed at 12585.08, up 0.37% [1]. - Focus Technology (002315) saw a significant increase of 9.20%, closing at 48.30, with a trading volume of 224,800 shares and a transaction value of 1.053 billion [1]. - Other notable performers included Sichuang Medical (300078) with an 8.20% increase, closing at 4.88, and Jiahe Meikang (688246) with a 6.45% increase, closing at 24.42 [1]. Group 2: Capital Flow - The internet healthcare sector experienced a net outflow of 89.6577 million from institutional investors, while retail investors saw a net inflow of 763 million [2]. - The leading stocks in terms of net inflow from retail investors included Focus Technology with a net outflow of 97.1479 million, and Jiahe Meikang with a net inflow of 46.0728 million [3]. - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are actively participating [2][3].